Jim Cramer said he’s a little nervous about stock of UPS (UPS) on word of that Amazon (AMZN) is to seeking to lessen its reliance on the company. The Wall Street Journal wrote that Amazon is looking at a shipping alternatives. ‘A spat with Amazon is not what you want right here,’ said Cramer, who’s portfolio manager of Action Alerts PLUS and host of CNBC’s ‘Mad Money.’ A viewer asked Cramer why stock of Toro (TTC) isn’t getting beat up, considering the warmer weather has impacted other companies that sell cold weather goods. Cramer said it’s a good question, but he’d steer clear of the stock. Cramer was also asked his views of the housing sector, and he said you can’t own housing stocks if the Federal Reserve decides to aggressively raise interest rates. Of the group, Cramer said Lennar (LEN) is the best, but he doesn’t recommend owning. Cramer was asked whether it’s safe to buy Chipotle (CMG), and he responded that he needs to take a look at the next quarterly report first. He was also asked about Kraft Heinz (KHC), which Action Alerts PLUS holds. Cramer said the stock is finally starting to make a comeback, and that it’s been ‘a real dog.’ Cramer answers viewers questions sent to his Facebook(FB) page. You can also send him questions on Twitter(TWTR), where he’s @jimcramer. Use hashtag Cramer Q.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.